SCHEMBL4310257

SCHEMBL4310257

COc1cc(-c2cc(=O)c3c(O)c(C)c(O)c(C)c3o2)cc(OC)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.61
▸ CYP3A4 P08684 2/20 0.61
▸ MAPT P10636 3/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ RECQL P46063 2/20 0.57
▸ AKR1B1 P15121 1/20 0.57
▸ MAOA P21397 1/20 0.57
▸ MAPK8 P45983 1/20 0.57
▸ MEN1 O00255 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ USP2 O75604 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ ELANE P08246 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ LCK P06239 1/20 0.52
▸ ABCB1 P08183 1/20 0.52
▸ ABCG2 Q9UNQ0 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30956242 0.88 ALDH1A1 (0.70) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL3320910 0.88 ALDH1A1 (0.70) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL7375373 0.80 GABRP (0.64) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL30269735 0.79 KMT2A (0.68) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL29615754 0.79 KMT2A (0.68) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL10013320 0.79 ABCB1 (0.64) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL28009934 0.77 TERT (0.58) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL22686278 0.76 KDM4E (0.82) MAPTKDM4EPOLBRECQLAKR1B1
Gardenin SCHEMBL1764114 0.76 ALDH1A1 (1.00) ALDH1A1CYP3A4MAPTKDM4EPOLB
SCHEMBL26110312 0.75 ALDH1A1 (0.75) ALDH1A1CYP3A4MAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1493431-B1 Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions MERCK PATENT GMBH (DE) 2009-09-30 — — EP disclosed
US-20080044502-A1 USE OF AN AQUEOUS OR HYDROALCOHOLIC EXTRACT OF BAUHINIA FOR THE PREPARATION OF A COMPOSITION WIRTH CORINNA 2008-02-21 — — US disclosed
US-20060188591-A1 Bauhinia extracts BUCHHOLZ HERWIG 2006-08-24 — — US disclosed
US-20050019426-A1 For care, protection from aging of skin and hair, use in treatment of various skin disorders such as leukoplakia, eczema, keratosis, psoriasis, or to promote wound healing MERCK PATENT GMBH (DE) 2005-01-27 — — US disclosed
EP-1493431-A2 Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions MERCK PATENT GmbH (DE) 2005-01-05 — — EP disclosed
EP-1414476-A1 BAUHINIA EXTRACTS MERCK PATENT GmbH (DE) 2004-05-06 — — EP disclosed
WO-2003011311-A1 BAUHINIA EXTRACTS MERCK PATENT GMBH (DE) 2003-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050019426-A1 For care, protection from aging of skin and hair, use in treatment of various skin disorders such as leukoplakia, eczema, keratosis, psoriasis, or to promote wound healing ITCH, CUTA, POLR1C ALDH1A1 1876/4885CYP3A4 4025/4885MAPT 730/4885
US-20080044502-A1 USE OF AN AQUEOUS OR HYDROALCOHOLIC EXTRACT OF BAUHINIA FOR THE PREPARATION OF A COMPOSITION BROX, HAAO, HIRA ALDH1A1 152/4885CYP3A4 1025/4885MAPT 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback